Side-by-side comparison of AI visibility scores, market position, and capabilities
Global investment bank and wealth manager with $61.9B FY2024 revenue; $7.5T client assets; E*Trade ($13B, 2020) and Eaton Vance ($7B, 2021) acquisitions anchored shift to 55% fee-based wealth revenue.
Morgan Stanley is a leading global financial services firm providing investment banking, securities, wealth management, and investment management services, founded in 1935 by Henry Sturgis Morgan (grandson of J.P. Morgan) and Harold Stanley after breaking away from J.P. Morgan & Co. following the Glass-Steagall Act separation of commercial and investment banking. Headquartered in New York City and trading on NYSE (MS), the company reported approximately $61.9 billion in net revenues for FY2024 under CEO Ted Pick, who succeeded the transformative James Gorman as CEO in January 2024. Gorman's decade-long strategy—shifting Morgan Stanley's revenue mix from volatile investment banking and trading toward stable fee-based wealth management—has resulted in the Wealth Management segment representing approximately 55% of net revenues, with $7.5 trillion in total client assets managed across 15,000+ financial advisors.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.